These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38019516)

  • 101. Cost-effectiveness of Compression Therapy With Early Endovenous Ablation in Venous Ulceration for a Medicare Population.
    Zheng H; Magee GA; Tan TW; Armstrong DG; Padula WV
    JAMA Netw Open; 2022 Dec; 5(12):e2248152. PubMed ID: 36542379
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents.
    Lim F; Bellows BK; Tan SX; Aziz Z; Woo Baidal JA; Kelly AS; Hur C
    JAMA Netw Open; 2023 Aug; 6(8):e2329178. PubMed ID: 37651143
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer.
    Teppala S; Scuffham PA; Tuffaha H
    Int J Technol Assess Health Care; 2024 Mar; 40(1):e14. PubMed ID: 38439629
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Use of MRI-Guided Biopsy for Selection and Follow-up of Men Undergoing Hemi-gland Cryoablation of Prostate Cancer.
    Zhou SR; Simopoulos DN; Jayadevan R; Felker ER; Delfin MK; Barsa DE; Kwan L; Marks LS
    Urology; 2019 Apr; 126():158-164. PubMed ID: 30659903
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Surveillance of Unruptured Intracranial Aneurysms: Cost-Effectiveness Analysis for 3 Countries.
    Cras TY; Hunink MMG; Dammers R; van Es ACGM; Volovici V; Burke JF; Kremers FCC; Dippel DWJ; Roozenbeek B
    Neurology; 2022 Aug; 99(9):e890-e903. PubMed ID: 35654593
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cost-Effectiveness of CT, CTA, MRI, and Specialized MRI for Evaluation of Patients Presenting to the Emergency Department With Dizziness.
    Tu LH; Melnick E; Venkatesh AK; Sheth KN; Navaratnam D; Yaesoubi R; Forman HP; Mahajan A
    AJR Am J Roentgenol; 2024 Feb; 222(2):e2330060. PubMed ID: 37937837
    [No Abstract]   [Full Text] [Related]  

  • 107. A decision analysis comparing 3 active surveillance protocols for the treatment of patients with low-risk prostate cancer.
    White C; Nimeh T; Gazelle GS; Weinstein MC; Loughlin KR
    Cancer; 2019 Mar; 125(6):952-962. PubMed ID: 30561761
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer.
    Quinn TP; Sanda MG; Howard DH; Patil D; Filson CP
    Cancer; 2021 Aug; 127(16):2974-2979. PubMed ID: 34139027
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The cost implications of prostate cancer screening in the Medicare population.
    Ma X; Wang R; Long JB; Ross JS; Soulos PR; Yu JB; Makarov DV; Gold HT; Gross CP
    Cancer; 2014 Jan; 120(1):96-102. PubMed ID: 24122801
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors.
    Wong FL; Lee JM; Leisenring WM; Neglia JP; Howell RM; Smith SA; Oeffinger KC; Moskowitz CS; Henderson TO; Mertens A; Nathan PC; Yasui Y; Landier W; Armstrong GT; Robison LL; Bhatia S
    J Clin Oncol; 2023 Feb; 41(5):1046-1058. PubMed ID: 36265088
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Cost-Effectiveness of Diffusion Weighted MRI Versus Planned Second-Look Surgery for Cholesteatoma.
    Patel TA; Ettyreddy A; Cheng T; Smith K; Sridharan SS; McCall AA
    Ann Otol Rhinol Laryngol; 2024 Jul; 133(7):665-671. PubMed ID: 38676449
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Cost-effectiveness of Intraoperative MRI for Treatment of High-Grade Gliomas.
    Abraham P; Sarkar R; Brandel MG; Wali AR; Rennert RC; Lopez Ramos C; Padwal J; Steinberg JA; Santiago-Dieppa DR; Cheung V; Pannell JS; Murphy JD; Khalessi AA
    Radiology; 2019 Jun; 291(3):689-697. PubMed ID: 30912721
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Cost-effectiveness analysis of different anesthesia strategies for transperineal MRI/US fusion prostate biopsy.
    Jin D; Kong XQ; Zhu YJ; Chen ZX; Wang XM; Xu CH; Pu JX; Hou JQ; Huang YH; Ji FH; Huang C
    Asian J Androl; 2024 Jul; 26(4):409-414. PubMed ID: 38376191
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis.
    Bindra J; Chopra I; Niewoehner J; Panaccio M; Wan GJ
    Clinicoecon Outcomes Res; 2021; 13():349-358. PubMed ID: 33986603
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk Populations.
    Peters MLB; Eckel A; Seguin CL; Davidi B; Howard DH; Knudsen AB; Pandharipande PV
    JCO Oncol Pract; 2024 Feb; 20(2):278-290. PubMed ID: 38086003
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis.
    Jiang X; Yao J; You JH
    J Med Internet Res; 2021 Mar; 23(3):e26516. PubMed ID: 33656440
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Common treatment strategies for calcium hydroxyapatite deposition disease: a cost-effectiveness analysis.
    Alaia EF; Subhas N; Da Silva Cardoso M; Li ZI; Shah MR; Alaia MJ; Gyftopoulos S
    Skeletal Radiol; 2024 Mar; 53(3):437-444. PubMed ID: 37580537
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.
    Vynckier P; Annemans L; Raes S; Amrouch C; Lindgren P; Májek O; Beyer K; Leenen RCA; Venderbos LDF; Denijs F; van Harten MJ; Helleman J; Chloupková R; Briers E; Vasilyeva V; Rivas JG; Basu P; Chandran A; van den Bergh RCN; Collen S; Van Poppel H; Roobol MJ;
    Eur Urol; 2024 May; ():. PubMed ID: 38789306
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.
    Ahern CH; Shih YC; Dong W; Parmigiani G; Shen Y
    Br J Cancer; 2014 Oct; 111(8):1542-51. PubMed ID: 25137022
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Surgical-decision making in the setting of unsuspected N2 disease: a cost-effectiveness analysis.
    Mitzman B; Varghese TK; Akerley WL; Nelson RE
    J Thorac Dis; 2024 Feb; 16(2):1063-1073. PubMed ID: 38505073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.